| Category | BioTech |
| Phone | 358-9319-36500 |
| Employees | |
| Founded | 1999 |
| TOTAL | $12.7M |
| VENTURE FUNDING TOTAL | $12.7M |
| Series C, 4/05 BioFund Management Sitra Ventures Varma Mutual Pension Insurance Company Finnish Industry Investment | $9.02M |
| Venture Round, 1/06 Innovations Kapital | $3.68M |
Ipsat Therapies, a biotechnology company, develops intestinal protection systems in antibiotic treatment. It focuses on the development of products for the prevention of antibiotic resistance, antibiotic-associated diarrhea, and hospital associated infections. The company offers bioengineered enzyme, which removes the excess unabsorbed harmful antibiotic in intestine and maintains a normal intestinal microflora. It also develops various antibiotics, including penicillin, cephalosporin, carbapenems, and fixed combination products. Ipsat Therapies Oy was founded in 1999 and is based in Helsinki, Finland.
